Join our mailing list!
(Your shopping cart is empty)
Diane Publishing Books
Oversight of Clinical Investigators: Actions Needed to Improve Timeliness and Enhance Scope of FDA’s Debarment and Disqualification Processes for Med. Report Investigators
Marcia Crosse (au)
The FDA oversees the clinical investigators who conduct research involving new drugs, biologics, and medical devices to ensure that their conduct does not compromise the safety of clinical trial participants or the integrity of clinical trial data. FDA can debar or disqualify investigators who have engaged in misconduct such as submitting fraudulent data. Debarred or disqualified investigators cannot engage in certain activities related to clinical research. This report reviewed FDA's debarment and disqualification processes. It examined the length of time that debarment and disqualification processes have taken and factors for those time frames, and the statutory and regulatory limitations of debarment and disqualification. Illus.
Comes the Millennium
Sexual Harassment: Women Speakout
Office Computing Bible: Using Personal Computers at Work
Competing for Employees: Proven Marketing Strategies for Hiring & Keeping Exceptional People
Share your knowledge of this product with other customers...
Be the first to write a review
Diane Publishing Co
PO Box 617
Darby, PA 19023-0617
Become an Affiliate
Send Us Feedback
Copyright ï¿½ 2004 Diane Publishing Company. All Rights Reserved.